← Leaderboards
Brian C. Leonard
University Of California At Davis
$1,501,709
Attributed
$1,501,709
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $426.8K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,501,709 · 2
By mechanism
K08$1,074,870 · 1
R21$426,839 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Christopher John Murphy$14,149,626
- Erin Alissa Hisey$136,394
Others in their field
Other Emerging Leaders on “Permeability”
- John Damon Chodera · Sloan-Kettering Inst Can Research$9,554,339
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$7,929,174
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$7,356,765
- Terry Roemer · Prokaryotics, Inc.$5,995,437
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$5,755,414
- Juan Du · Van Andel Research Institute$5,564,938
Research focus
PermeabilityCorneaAffectProteinsEpithelial CellsIn VivoKnockout MiceSurfaceCorneal EpitheliumDrug Delivery SystemsCuesClinically SignificantAftercareBiophysicsDesignEpithelialClinical ApplicationCorneal DiseasesCorneal InjuryCorneal ScarClustered Regularly Interspaced Short Palindromic RepeatsAnteriorCell SurvivalComplement Factor B
Grant awards (6)
Defining a new model of evaporative dry eye disease$426,839
R21 · FY2025 · EY · contact PI
Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration$214,974
K08 · FY2021 · EY · contact PI
Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration$214,974
K08 · FY2020 · EY · contact PI
Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration$214,974
K08 · FY2019 · EY · contact PI
Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration$214,974
K08 · FY2018 · EY · contact PI
Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration$214,974
K08 · FY2017 · EY · contact PI